Jak interpretovat účinnost léčby novými antitrombotiky ve výsledcích laboratorních testů
| Title in English | How to interpret efficacy of treatment with new antithrombotics in results of laboratory tests |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Article in Periodical |
| Magazine / Source | Postgraduální medicína |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | DOAC; dabigatran; rivaroxaban; apixaban; edoxaban; laboratory examination |
| Description | Introducing direct peroral anticoagulants into clinical practice brings a substantial advance in anticoagulation therapy and it has indisputable benefits compared to the traditional treatment with vitamin K antagonists. At the samé time, this modern treatment has its possible pitfalls, such as interpre-tation of coagulation tests. In patients using direct anticoagulants it is usually not necessary to monitor the treatment regularly, but in some cases, a laboratory examination of coagulation rates is necessary. It is also necessary to keep in mind that these preparations can influence a whole range of both routine and speciál coagulation tests, which always needs to be kept in mind when interpreting results. |
| Related projects: |